HESPAN (B. Braun Medical Inc.)
Welcome to the PulseAid listing for the HESPAN drug offered from B. Braun Medical Inc.. This Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [Chemical/Ingredient],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | B. Braun Medical Inc. |
| NON-PROPRIETARY NAME: | Hetastarch in Sodium Chloride |
| SUBSTANCE NAME: | HETASTARCH; SODIUM CHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [Chemical/Ingredient],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1991-04-04 |
| END MARKETING DATE: | 0000-00-00 |
HESPAN HUMAN PRESCRIPTION DRUG Details:
| Item Description | HESPAN from B. Braun Medical Inc. |
| LABELER NAME: | B. Braun Medical Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 6; .9(g/100mL; g/100mL) |
| START MARKETING DATE: | 1991-04-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0264-1965_5181c451-ce09-45e1-bb89-7190866c65d4 |
| PRODUCT NDC: | 0264-1965 |
| APPLICATION NUMBER: | BN890105 |
Other HETASTARCH; SODIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:
